A detailed history of Mv Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mv Capital Management, Inc. holds 266,603 shares of ABBV stock, worth $47.2 Million. This represents 5.72% of its overall portfolio holdings.

Number of Shares
266,603
Previous 265,610 0.37%
Holding current value
$47.2 Million
Previous $45.6 Million 15.57%
% of portfolio
5.72%
Previous 5.21%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $162,693 - $197,934
993 Added 0.37%
266,603 $52.6 Million
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $13,002 - $15,183
84 Added 0.03%
265,610 $45.6 Million
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $85,663 - $97,605
536 Added 0.2%
265,526 $48.4 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $11,008 - $12,397
80 Added 0.03%
264,990 $41.1 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $60,115 - $69,592
450 Added 0.17%
264,910 $39.5 Million
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $297,749 - $370,530
-2,247 Reduced 0.84%
264,460 $35.6 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $5.74 Million - $6.6 Million
39,660 Added 17.47%
266,707 $42.5 Million
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $23,927 - $28,695
173 Added 0.08%
227,047 $0
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $510,534 - $585,549
-3,804 Reduced 1.65%
226,874 $30.4 Million
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $5.27 Million - $6.7 Million
38,307 Added 19.91%
230,678 $35.3 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $12,010 - $14,901
91 Added 0.05%
192,371 $31.2 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $19 Million - $24.1 Million
177,222 Added 1176.93%
192,280 $26 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $88,844 - $100,851
835 Added 5.87%
15,058 $1.62 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $71,753 - $79,937
682 Added 5.04%
14,223 $1.6 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $169,511 - $186,611
1,657 Added 13.94%
13,541 $1.47 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $110,110 - $148,660
1,368 Added 13.01%
11,884 $1.27 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $499,996 - $586,830
5,820 Added 123.94%
10,516 $921,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $318,132 - $425,708
4,336 Added 1204.44%
4,696 $461,000
Q1 2020

Apr 28, 2020

SELL
$64.5 - $97.79 $1,677 - $2,542
-26 Reduced 6.74%
360 $27,000
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $3,173 - $3,971
-44 Reduced 10.23%
386 $34,000
Q3 2019

Nov 21, 2019

BUY
$62.98 - $75.72 $1,763 - $2,120
28 Added 6.97%
430 $33,000
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $1,116 - $1,427
-17 Reduced 4.06%
402 $29,000
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $462 - $544
6 Added 1.45%
419 $34,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $5,060 - $6,240
65 Added 18.68%
413 $38,000
Q3 2018

Nov 06, 2018

BUY
$88.91 - $98.84 $4,089 - $4,546
46 Added 15.23%
348 $33,000
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $21,094 - $26,944
302
302 $27,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.